The health venture led by Dr. Atul Gawande is working with a global consulting powerhouse to hone its strategy for improving care of chronically ill patients who account for the vast majority of medical costs, according to a person familiar with the arrangement.

The partnership with Boston-based Monitor Group, the business consulting arm of Deloitte, signals a desire to deliver stepped-up services — enabled by data and modern technology — to frequent users of health care within Amazon, Berkshire Hathaway, and JPMorgan Chase, the companies that hired Gawande to rein in their 1.2 million employees’ health spending.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy